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GENOTYPE DISTRIBUTION OF THE GB VIRUS C IN CITIZENS OF SÃO PAULO CITY, BRAZIL
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SUMMARY
There has been several studies worldwide on phylogenetics and genotype distribution of the GB-virus C / Hepatitis G virus
(GBV-C/HGV). However, in their great majority, those investigations were based on some epidemiologically linked group, rather
than on a representative sampling of the general population.  The present is a continuation of the first study in Brazil with such a
population; it addresses the GBV-C/HGV phylogenetics and genotype distribution based on samples identified among more than
1,000 individuals of the city of São Paulo. For this purpose, a 728 bp fragment of the 5´non-coding region (5´NCR) of the viral
genome, from 24 isolates, was sequenced and subjected to phylogenetic analysis.  Genotypes 1, 2a and 2b were found at 8.3% (2/24),
50% (12/24) and 41.7% (10/24), respectively. In conclusion São Paulo displays a genotype distribution similar to the published data
for other States and Regions of Brazil, endorsing the notion that types 1 and 2 would have entered the country with African and
European people, respectively, since its earliest formation.
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INTRODUCTION
In the mid nineties two independent groups - looking for a new virus
that could be an etiologic agent for the non-A-E hepatitis cases - isolated
the Flaviviridae RNA virus, today, collectively referred to as GBV-C/
HGV (GBvirus-C/Hepatitis G Virus)19,39. Due to its efficient parenteral
transmission, the GBV-C/HGV has been found at high prevalence (14 –
45%) in different groups worldwide exposed to transfused-blood and -
hemocomponents and  in  intravenous drug users10,38.
Other illness-related groups have also been found to present high
frequency of this virus: 3 to 55% in hemodialyzed patients20,45, 15 to
61% in subjects who underwent organ transplant31,40 and 15 to 21% in
patients with post-transfusional hepatitis14,43.
Nonetheless, the GBV-C/HGV has not been confirmed to be the
causal agent of the non-A-E hepatitis or of any other disease. Besides,
this virus is widely present in healthy subjects, such as blood donors,
with variable prevalence: 1 to 3% in Japan and USA1,34 and more than
10% in some African and other developing countries4,5.
After all, the interest in the GBV-C/HGV has recently been restored
- as a benevolent rather than a villain agent - for the allegedly association
between its infection and a favorable clinical outcome from HIV-co-
infected patients44. Yet disputable32, this possibility should be further
investigated and data on GBV-C/HGV epidemiology, including genotype
distribution, should be made available and may be valuable information.
The ubiquitous presence of this virus can be explained by the different
ways of transmission it has been associated with: vertical49,50, sexual12,32
and, possibly, blood-sucking insects30.
In Brazil, previous studies reported values for the GBV-C/HGV RNA
prevalence in blood donors from 5.5 to 9.7% in the city of São Paulo3,17,29,
and in Rio de Janeiro of about 8.2%15. Moreover, our study with a large
sampling (1,039 subjects) of the general population of the city of São
Paulo showed similar figure: 5.1% RNA positive samples30.
The GBV-C/HGV presents a genomic structure similar to the
Hepatitis C virus (HCV): a single RNA molecule of about 10 Kb16,19.
Different genome regions were considered to study genetic variability
in various populations throughout the world. In general, the coding
regions – NS39,28, NS4b, NS5a and NS5b13,48 have not produced consistent
phylogenetic analyses for a GBV-C/HGV classification. Conversely, other
studies did lead to genotype classifications by sequencing (i) the non-
coding regions – 5’NCR2,18,19,22,42 (ii) a portion of the coding region for
the viral envelope41 and (iii) the complete GBV-C/HGV genome24,41.
Those studies on strains from various part of the world revealed five
different genotypes of the HGV/GBV-C: type 1, predominantly found
in Western Africa, 2 in Europe and America, 3 in Asia21,42 and, more
recently, the subtypes 4 and 5 in Southeast Asia and South of Africa,
respectively 23,35,36,41,46,47.
There are some data on HGV/GBV-C genotype distribution in Brazil.
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GALLIAN et al.8 have described two genotypes (1 and 2) in a rural
population of the Northeast region. Yet in this region, PEREIRA et al.27
have found, besides 1 and 2, the genotype 3 in patients co-infected with
the hepatitis C virus (HCV).
In the work of FOCCACIA et al.7 more than one thousand subjects
were chosen upon specific criteria to allow an epidemiological survey in
a representative sampling of the city of São Paulo. Those are invaluable
sources for studying phylogenetics and genotype distribution, and no
one has so far investigated such a population for these purposes; of those
1,039 samples, 53 turned out to be positive for GBV-C/HGV RNA30 and
are the subjects of the present work.
MATERIALS AND METHODS
Serum samples
The serum specimens were collected between February and May,
1996, in a previous cross-sectional study - conducted to estimate the
prevalence of viral hepatitis infection in the city of São Paulo, Brazil7.
Of those, RNA extraction and RT-PCR (see below) were carried out
from 1,039 samples; the 53 positive samples described in our previous
work30 are the subjects of the present study.
The use of those samples for investigating HGV, among other viruses,
was approved by the Committee of Ethical Research of the Institute of
Infectology Emilio Ribas (São Paulo, SP);  all subjects signed their
informed consent.
RNA extraction and GBV-C/HGV reverse transcription and
polymerase chain reaction (RT-PCR)
One hundred µl of serum were added to a 300 µl Trizol (GIBCO-
BRL, EUA) solution following the protocol of the INNO-LIPATM HCV
II (Innogenetics N.V., Belgium). The RNA-dry precipitate was dissolved
in 12 µl of Milli-Q/Millipore water treated with dietilpyrocarbonate
(DEPC) containing 300 ng of random primer (Random Primer –
Pharmacia Biotech, Sweden); the solution was kept at 70 °C for 10
minutes. The cDNA synthesis was carried out by the addition of 200 U
of Super Script TM II  reverse transcriptase (GIBCO BRL)  in a buffer
solution with  5 U of ribonuclease inhibitor (GIBCO BRL)  and 0.5mM
deoxyribonucleosides trifosfate (dNTPs by Pharmacia or GIBCO BRL)
at 42 °C, for 1.5 hour, at a final  volume of 20 µl.
Polymerase chain reaction (PCR)
A fragment of the 5’ non-coding region (5’NCR) was amplified in a
reaction mixture containing 20 µl of the cDNA solution, 20 µl of the
primer-mix solution with 40 pmol of FV94-22F FV94-22F - 5’-
GCAAGCCCCAGAAACCGACGCCTATCTAAGT-3’ - and FV94-724F
- 5’-GCACAGCCAAACCCGCCTGATACAGT-3’ -18, 2U Taq-DNA-
Polymerase (GIBCO BRL), 1.5mM MgCl2 (GIBCO BRL) to a final volume
of 100 µl. The reaction was performed in a PTC 200 MJ Research, Peltier
Thermal Cycler as follows: an initial step at 95 °C for 5 minutes, followed
by 40 cycles of 94 °C for 30 seconds, 55 °C for 30 seconds and 72 °C for
30 seconds, and a final extension period of 10 minutes at 72 °C. The 728
bp amplified fragment covers nucleotides 39 to 766 of the 5’NCR in relation
to sequence of accession number   D87715.
After amplification, 5 µl of the PCR product was used for
electrophoresis analysis on a 2% agarose gel.
PCR control: in each experiment, along with a maximum number
of 15 test samples, two water samples and one GBV-C RNA positive
sample were included for checking reproducibility of GBV-C RNA
extraction, reverse transcription and amplification.
Sequencing and genotyping
The 728 bp PCR product was purified with the QIAquick kit
(QIAGEN, Germany), and directly sequenced in the ABI 310 and  377
sequencer with the ABI PRISM Big Dye Terminator Cycle Sequencing
Ready Reaction (PE Applied Biosystems), following their protocol. The
sequences were edited using the NAVIGATOR program (Applied
Biosystems) and aligned with the sequences of the three main subtypes
(Fig. 1) with the CLUSTAL X program11. The phylogenetic analysis
was carried out with the PHYLIP 3.5c program6. Bootstrap values were
determined on 500 replicates of the sequence data with the SEQBOOT
program. Phylogenetic reconstructions were generated by the Neighbor-
Joining program33, and the distances were calculated by the maximum
likelihood with the DNADIST program. The consensus tree was produced
by the PAUP program (50% majority rule).
Fig. 1 - Phylogenetic tree showing the relative evolutionary distance between the GBV-C/
HGV genotypes. Bootstrap analysis values for each genotype are boxed. Red  numbers are
referred to sequences from this work. The remaining sequences are identified by their Genbank
accession number.
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RESULTS
Of the 53 GBV-C/HGV positive samples subjected to PCR
amplification, 24 yielded the NCR fragment (728 bp) at concentrations
enough for automated sequencing, whereas nineteen produced
insufficient material and 10 no detectable yield.
The phylogenetic analysis - carried out with standard strains - has
revealed the genotypes 1, 2a and 2b, at 8.3% (2/24), 50% (12/24) and
41.7% (10/24), respectively (Fig. 1).
DISCUSSION
Sequencing and phylogenetic analysis based on the 5’ non-coding
region (5’NCR) of nearly half (24/53) of the GBV-C/HGV positive
isolates from a large sampling (1,039) of the city of São Paulo disclosed
the following genotypes: 1 (8.3%), 2a (50%) and 2b (41.7%).
OLIVEIRA et al.25 conducted a study with samples from blood donors
of the Central Region of Brazil (Goiânia, capital of the State of Goiás),
based on the same genome region of the GBV-C/HGV (5’NCR). They
reported similar genotype distribution – 2b (58.9%), 2a (23.5%) and 1
(17.6%) – as determined by restriction fragment length polymorphism25.
Studying the 5’ untranslated region (5’UTR – another denomination
for the non-coding region) of the GBV-C/HGV genome in isolates from a
rural population from Bahia (Northeast of Brazil), GALLIAN et al.8 have
also found type 1 (6/35, 17.1%) and type 2  (29/35, 82.9%). Also in the
Northeast region, but in patients co-infected with HCV, PEREIRA et al.27
have found, besides type 1 (1a, 5.3%; 1b, 44.7%) and 2 (3.5%), type 3
(41.2%) and mixed infections (5.3%) with more than one of these genotypes.
In the neighbor country Argentina, among 21 GBV-C/HGV positive
samples from human immunodeficiency virus (HIV)-infected intravenous
drug users, the same genotypes were found: 1 (4.8%), 2a (52.4%) 2b
(19%) and 3 (23.8%); whereas in eleven blood donors they found
genotypes 2a (45.5%), 2b (45.5%) and 3 (9.1%)26.
In conclusion, genotypes 1 and 2 are present in southeastern- and
northeastern- Brazilian populations, being type 2 relatively predominant
in both cases. However, when studying samples from HCV- and HIV-
mixed infections, in Brazil and Argentina, genotype 3 appears at high
frequencies (see above). The high prevalence of type 3 in more exposed
groups might be a consequence of its later entrance in those populations
through parenteral and/or sexual route. While types 1 and 2 would have
entered the country with African and European people, respectively, since
its earliest formation.
RESUMO
Distribuição  dos genótipos  do vírus GB-C (HGV) em indivíduos
da cidade de São Paulo, Brasil
Há na literatura vários estudos filogenéticos e de distribuição de
genótipos do chamado “Vírus GB-C” ou da “Hepatite G”, mais conhecido
pela dupla sigla “GBV-C/HGV”. Ocorre que, em sua grande maioria, estas
pesquisas foram realizadas com amostras de grupos ligados
epidemiologicamente e não com indivíduos representativos da população
geral. O presente estudo é uma continuação do primeiro trabalho no Brasil
feito com este tipo de amostragem. Trata-se de análise filogenética e
distribuição genotípica do GBV-C/HGV a partir de amostras isoladas dentre
mais de 1.000 indivíduos da cidade de São Paulo. Para tanto, um fragmento
de 728 pares de base da região 5’ não-codificadora  (5´NCR) do genoma
viral, de 24 amostras, foi sequenciado  e submetido à analise filogenética.
Foram identificados os genótipos 1, 2a e 2b nas respectivas freqüências:
8,3% (2/24), 50% (12/24) e 41,7% (10/24). Concluindo, São Paulo
apresenta uma distribuição de genótipos semelhante à publicada para outros
estados e regiões do Brasil, endossando a idéia de que os tipos 1 e 2
teriam vindo com os africanos e europeus, respectivamente, e portanto
estariam na população do país desde a sua formação.
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